Comparison of Haemodynamic Effects During Orotracheal Intubation, by Direct or Indirect Laryngoscopy With Airtraq (HEMODAIRTRAQ)

March 25, 2020 updated by: University Hospital, Lille

Comparison of Haemodynamic Effects During Orotracheal Intubation, by Direct or Indirect Laryngoscopy With Airtraq, Controlled, Prospective, Randomized, Simple-blind, Monocentric Study at the Lille University Hospital Specialties Block.

News techniques of intubation by indirect laryngoscopy have arrived in operating rooms but they are still too restricted to situations (difficult intubation criteria ..). It wanted to focus on indirect laryngoscopy by Airtraq. This technique allows better exposure during intubation while limiting mouth opening and cervical hyper extension, but also dental trauma and lip wounds. It also reduces the duration of laryngoscopy and therefore at the same time the apnea time. After a review of the literature, it has been proven that its use reduces haemodynamic changes during intubation. But these studies have been realized only in very particular patients (obese, heart failure) and with induction protocols that are not used routinely in our operating theaters.

Reasons why it decided to carry out this study, on the one hand to find these results and especially to be able to extend them to the whole population.

Study Overview

Study Type

Interventional

Enrollment (Actual)

218

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lille, France
        • Hôpital Roger Salengro, CHU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Specific medical conditions: ASA 1 or 2
  • Patient having given written consent to participate in the category 2 trial
  • Intubation realized by experienced person
  • Social Insured Patient
  • Patient willing to comply with all procedures of the study and its duration

Exclusion Criteria:

  • Demographic characteristics: minor, over 65
  • Medical history: history of difficult intubation, hypertension
  • Lille intubation score greater than or equal to 7
  • Treatments in progress: Beta taking blocking the day of the operation.
  • Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of coverage by the social security system, refusal to sign consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: orotracheal intubation direct
Orotracheal intubation by direct laryngoscopy by metal blade type Macintosch
OTHER: orotracheal intubation indirect
orotracheal intubation by indirect laryngoscopy by Airtraq

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
change from intubation mean blood pressure at 1 min after intubation
Time Frame: between the values before intubation (T0) and 1min after intubation.
between the values before intubation (T0) and 1min after intubation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of patients with hemodynamic reaction post intubation (minimal variation of mean blood pressure or heart rate of 20%
Time Frame: between values before intubation and 1, 2, 5, 10 minutes after intubation.
between values before intubation and 1, 2, 5, 10 minutes after intubation.
Variation of blood pressure (PAM)
Time Frame: between the values before intubation (T0) and 2, 5 and 10 minutes of intubation
between the values before intubation (T0) and 2, 5 and 10 minutes of intubation
Variation of heart rate (HR)
Time Frame: between the values before intubation (T0) and 1, 2, 5 and 10 minutes of intubation
between the values before intubation (T0) and 1, 2, 5 and 10 minutes of intubation
Mean of the arterial blood pressure and heart rate
Time Frame: before intubation and at 1,2,5 and 10 minutes from intubation.
delta defined by the difference between the values
before intubation and at 1,2,5 and 10 minutes from intubation.
Intubation time in seconds from introduction of the intubation device into the mouth with inflation of the balloon
Time Frame: at 1 min after intubation
at 1 min after intubation
Frequency of patients with dental trauma and / or an injury to the lips due to the intubation device.
Time Frame: at 10 min after intubation
at 10 min after intubation
instantaneous ANI delta
Time Frame: between ANI before intubation and 1,2,5 and 10 min after intubation
between ANI before intubation and 1,2,5 and 10 min after intubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 4, 2018

Primary Completion (ACTUAL)

July 31, 2019

Study Completion (ACTUAL)

July 31, 2019

Study Registration Dates

First Submitted

November 14, 2018

First Submitted That Met QC Criteria

November 15, 2018

First Posted (ACTUAL)

November 16, 2018

Study Record Updates

Last Update Posted (ACTUAL)

March 26, 2020

Last Update Submitted That Met QC Criteria

March 25, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2017_72
  • 2018-A01683-52 (OTHER: ID-RCB number, ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orotracheal Intubation

Clinical Trials on orotracheal intubation by direct laryngoscopy

3
Subscribe